Stocks · Healthcare · Medical - Devices
CapsoVision, Inc. CV
$6.17 -2.37% Close, Oct 2, 2026 · NASDAQ · Market cap $308.3M
Next earnings report: Nov 12, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is 57% below its highest close of the past year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- The diluted share count rose 7.8% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 46%
- Revenue growth accelerationBottom 37%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 4%
- Gross marginBottom 34%
- Operating marginBottom 26%
- Accruals (lower is better)Top 32%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 46%
- Free-cash-flow yieldBottom 38%
- EBITDA / enterprise valueBottom 39%
- Sales / enterprise valueBottom 19%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 46%
- 6-month returnBottom 26%
- 1-year return vs S&P 500Top 35%
- Distance from 52-week highBottom 17%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 28%
- Consecutive EPS beatsBottom 20%
- Upside to consensus price targetBottom 43%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 49%
- Maximum drawdown, 3 yearsTop 47%
- Beta vs S&P 500 (lower is better)Top 1%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 12.6% | 11.0% | ↓ |
| Gross margin | 53.5% | 50.9% | ↓ |
| Operating margin | -163.6% | -158.6% | ↑ |
| FCF margin | -176.1% | -200.8% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 11.0% | 12.6% | ↓ | Top 46% |
| Gross margin | 50.9% | 53.5% | ↓ | Bottom 34% |
| Operating margin | -158.6% | -163.6% | ↑ | Bottom 26% |
| Net margin | -214.7% | -163.3% | ↓ | — |
| Free-cash-flow margin | -200.8% | -176.1% | ↓ | — |
| Return on invested capital | -159.1% | — | Bottom 4% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -10.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 10.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +11.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -4.42%
- Shareholder yield
- -4.42%
- Share count change, 1 year
- +7.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 6
- Average EPS surprise, last 4
- -11.6%
- Average 2-day reaction, last 8
- -0.9%
- Positive 20 days after report
- 1 of 5
Analysts
- Consensus price target
- $9.00
- Target vs current price
- +45.9%
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | -15.4% | -1.0% | -10.8% | -5.0% | — |
| May 14, 2026 | -15.4% | +4.3% | -7.4% | -1.6% | -4.6% |
| Mar 26, 2026 | +5.9% | -8.9% | -19.6% | -30.2% | -21.6% |
| Nov 13, 2025 | -21.4% | +2.3% | -3.8% | +160.3% | -15.3% |
| Aug 14, 2025 | -1736.4% | -1.2% | -3.2% | -9.1% | +17.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.15 | -$0.13 | -15.4% | $3.6M |
| May 14, 2026 | -$0.15 | -$0.13 | -15.4% | $2.8M |
| Mar 26, 2026 | -$0.16 | -$0.17 | +5.9% | $3.9M |
| Nov 13, 2025 | -$0.17 | -$0.14 | -21.4% | $3.5M |
| Aug 14, 2025 | -$2.02 | -$0.11 | -1736.4% | $3.3M |
| May 9, 2025 | -$1.31 | -$0.11 | -1090.9% | $2.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 21.59× | — | — | Bottom 19% |
| Free-cash-flow yield | -9.05% | — | — | Bottom 38% |
| Earnings yield | -10.21% | — | — | Bottom 46% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -1.9%
- 200-day average slope (20 days)
- -1.5%
- Distance from 50-day average
- -3.4%
- Distance from 200-day average
- -7.7%
- RSI (14)
- 46.5
- Relative volume
- 0.43×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 55.0%
- Volatility vs own 5-year history
- 6th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- -1.44
- Correlation with S&P 500
- -0.15
- Current drawdown from 1-year high
- -57.2%
- Maximum drawdown, 3 years
- -67.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 11, 2025 | Feb 19, 2026 | -67.8% | 46 days | Not yet recovered |
| Jul 9, 2025 | Sep 9, 2025 | -27.2% | 43 days | 31 days (Oct 22, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $308.3M
- EPS, diluted (TTM)
- -$0.63
- Revenue (TTM)
- $13.9M
- 52-week range
- $4.38 – $15.37
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Revenue | $9.8M | $11.8M | $13.6M |
| Gross profit | $5.5M | $6.4M | $7.2M |
| Operating income | -$11.3M | -$19.9M | -$25.5M |
| Net income | -$11.3M | -$19.9M | -$25.3M |
| EPS (diluted) | -$0.29 | -$0.43 | -$0.54 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M | $3.5M | $2.8M | $3.3M | $3.5M | $3.9M | $2.8M | $3.6M |
| Net income | -$5.8M | -$4.6M | -$5.4M | -$4.6M | -$7.9M | -$7.4M | -$7.0M | -$7.5M |
| EPS (diluted) | -$0.14 | -$0.10 | -$0.12 | -$0.10 | -$0.17 | -$0.16 | -$0.15 | -$0.15 |
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Operating cash flow | -$10.8M | -$20.1M | -$22.9M |
| Capital expenditure | -$754,000 | -$153,000 | -$90,000 |
| Free cash flow | -$11.6M | -$20.2M | -$23.0M |
| Dividends paid | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $26.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $9.1M
- Total assets
- $18.6M
- Total liabilities
- $5.4M
- Total debt
- $687,000
- Net debt
- -$8.4M
- Shareholders’ equity
- $13.2M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 1,899,065
- Days to cover
- 11.67
- Change vs previous report
- +1.0%
FINRA short interest, settlement date Sep 15, 2026.